Scientists at Ames National Laboratory, in collaboration with Indranil Das's group at the Saha Institute of Nuclear Physics ...
B. Riley lowered the firm’s price target on PDS Biotechnology (PDSB) to $3 from $5 and keeps a Buy rating on the shares. The shares remain attractively valued with near-zero EV that fails to reflect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback